CereMetrix® has the capability to help millions suffering from chronic brain disorders.
Denver, Colorado (PRWEB) August 30, 2016
CereScan has teamed up with The Ohio State University (OSU) Department of Biomedical Informatics (BMI) to further develop its functional brain imaging diagnostic database and analytical tool, CereMetrix®.
The CereMetrix® system is designed to help improve the way complex brain disorders are diagnosed and treated by providing researchers and medical practitioners with quantitative imaging data and clinical information analysis through advanced processing. Today, the ever-expanding data warehouse includes over 6,600 scan encounters, including patients’ medical histories, family histories, symptoms, prior treatments, incoming diagnoses, outgoing diagnoses and brain scan data.
Using OSU’s Biomedical Informatics’ expertise in analyzing high-dimensional biological data, the collaborative project focuses on reprocessing imaging data in the department’s functional brain imaging databank. Each scan is composed of over 262,000 data points that measure perfusion levels in up to 160 brain regions derived from comparisons to normative data. The University’s knowledge and accomplished staff will help ensure CereScan’s state-of-the-art software and CereMetrix® data is consistent and meets industry standards.
“The collaboration between BMI and CereScan is beneficial to both of our organizations,” said Kimerly Powell, PhD, Director of Small Animal Imaging and Assistant Professor of Biomedical Informatics at OSU. “While we are contributing our expertise and resources to help build an innovative diagnostic tool, the project allows us to assist in developing an emerging, patented technology into a real world application that is useful and relevant to the research and medical communities.”
Slated for a 2017 release date, CereMetrix® is a machine learning ecosystem that provides doctors with the most likely diagnoses and therapy regimens for their patient’s brain health. Each new patient’s data will be compared to a library of de-identified patients with similar brain patterns, medical histories, and clinical symptoms.
“OSU’s Biomedical Informatics staff and their expertise in post-processing imaging has been nothing short of exemplary,” said Shane Quint, Chief Technology Officer of CereScan. “Their work provides a solid foundation for CereMetrix’s advanced image processing component to be built upon. With the ability to analyze thousands of brain scan encounters at once to find distinct pattern abnormalities CereMetrix® has the capability to help millions suffering from chronic brain disorders.”
CereScan is the nation’s leader in providing statistically measured brain diagnostics based on a new generation of imaging software, PET/CT (Positron Emission Tomography/Computed Tomography) and qSPECT (quantitative Single Photon Emission Computed Tomography) neuroimaging technologies. Referring and treating medical experts can rely on CereScan to offer differentiated diagnoses on a wide array of brain-based disorders.
About The Ohio State University’s Department of Biomedical Informatics
Established in 2001, the mission of The Ohio State University (OSU) Department of Biomedical Informatics (BMI) is to improve people’s lives through innovation in research, education, and patient care. To achieve this, BMI is pursuing the advancement of health and biomedicine through the development, application, and dissemination of novel biomedical informatics theories and methods capable of driving biological discovery, generating and translating knowledge, and advancing personalized healthcare. The department is led by a team consisting of Dr. Peter J. Embi (Interim Chair), Dr. Soledad Fernández (Associate Chair), and Dr. Kun Huang (Division Director of Computational Biology and Bioinformatics) – all recognized as international leaders in the application of biomedical informatics theories and methods to advance clinical and translational science. For more information, please visit go.osu.edu/BMI.
CereMetrix® is a unique brain diagnostic system and ever-expanding data warehouse that today includes over 6,600 scan encounters, including patients’ medical histories, family histories, symptoms, prior treatments, incoming diagnoses, outgoing diagnoses, and brain scans, among other data points. Each scan is composed of over 262,000 data points that measure perfusion levels in up to 160 brain regions derived from comparisons to normative data.
CereScan combines state-of-the-art qSPECT and PET/CT brain imaging technologies with a patient centered model of care to provide the highest level of neurodiagnostics anywhere. Using quantitative functional brain imaging, advanced imaging software, and an extensive library of clinical data, the CereScan medical team provides physicians with unmatched objective diagnostic information. CereScan helps patients and their physicians better understand the neurological basis of their conditions. In a variety of legal settings, CereScan provides objective evidence to attorneys and their clients regarding traumatic and toxic brain injuries. For researchers, CereScan provides independent pre- and post-treatment measures of organic changes in the brain along with measures of symptoms related to the brain disorder of interest. For more information, please call (866) 722-4806 or visit http://www.CereScan.com. Connect with CereScan on Twitter @CereScan and on Facebook at Facebook.com/CereScan.